期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

促红细胞生长素抵抗的发病机制研究新进展 被引量：10

下载PDF
导出
摘要 肾性贫血是慢性肾脏病（CKD）患者最常见的并发症之一,严重影响CKD患者的生活质量和生存率。促红细胞生长素（EPO）分泌的相对或绝对不足以及红细胞寿命的缩短是慢性肾衰竭肾性贫血的主要原因。研究显示红细胞寿命的缩短与维持性血液透析患者的营养状态、炎症状态及EPO抵抗有关[1]。2012年KDIGO（改善全球肾脏病预后组织）发布CKD患者贫血治疗指南：
作者 赵颖丹 顾波
机构地区 上海市静安区中心医院 复旦大学附属华山医院静安分院肾内科血透室
出处 《中国中西医结合肾病杂志》 2012年第10期924-925,共2页 Chinese Journal of Integrated Traditional and Western Nephrology
关键词 促红细胞生长素 维持性血液透析患者 发病机制 慢性肾脏病 红细胞寿命 肾性贫血 慢性肾衰竭 EPO抵抗
分类号 R692 [医药卫生—泌尿科学]
  • 相关文献

参考文献21

  • 1吴恩亮,高芳,刘玉芳,吕欣.虫草制剂联用促红细胞生成素治疗血透患者肾性贫血的临床研究[J].中国中西医结合肾病杂志,2010,11(4):351-352. 被引量：7
  • 2Macdougall IC, Cooper AC. Erythropoietin resistance:the role of in flammation and pro - inflammatory cytokines. Nephrol Dial Transplant,2002,17 ( suppl 11 ) : 39.
  • 3Cooper AC, Breen CP, Vyas B, et al. Poor response to recombi- nant erythropoietin is associated with loss of T - lymphocyte CD28 expressionand altered interleukin - 10 production. Neph- rol Dial Transplant,2003,18( 1 ) :133 - 140.
  • 4National Kidney Foundation. KDOQI Clinical Practice Guideline- sand Clini Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis ,2006,47 ( suppl 3 ) : 1.
  • 5Sitter T, Bergner A, Schiffl H. Dialysate related cy2 tokine induc- tio n and response to recombinant human erythropoietin in hae- modialysis patient s. Nephrol Dial Transplant,2000,15 ( 8 ) : 1207 - 1211.
  • 6Won HS,Kim HG,Yun YS,et al. IL-6 is an independent risk factor for resistance to erythropoiesis - stimulating agents in he- modialysis patients without iron deficiency. Hemodial Int, 2012, 16(1) :31 -37.
  • 7陈婷,江黎明,唐德燊,陈孝文.单核因子与终末期肾脏病并发症[J].国外医学（泌尿系统分册）,2004,24(2):254-257. 被引量：7
  • 8Mpio I, Boumendjel N, Karaaslan H, et al. Secondary hyperpara- thyroidism and anemia. Effects of a calcimimetic on the control of anemia in chronic hemodialysed patients. Nephrol Ther, 2011,7 (4) :229 -236.
  • 9. Courbebaisse M, Souberbielle JC. Phosphocalcic metabolism: regulation and explorations. Nephrol Ther, 2011,7 ( 2 ) : 118 - 138.
  • 10Vota DM, Crisp RL, Nesse AB, et al. Oxidative stress due to a- luminum exposure induces eryptosis which is prevented by erythropoietin. J Cell Biochem,2012,113 (5) : 1581 - 1589.

二级参考文献29

  • 1Gimdt M, Kaul H, Leitnaker CK, et al. Selective sequestration of cytokineproducing monocytes during hemodialysis treatment. Am J Kidney Dis,2001.37(5).954 - 63.
  • 2Pecoits-Filho R, Barany P,Lindholm B,et al. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment . Nephrol Dial Transplant,2002,17(9), 1684 - 8.
  • 3Bologa RM, Levine DM,Parker TS,et al. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia , and mortality in hemodialysis patients. Am J Kidney Dis, 1998,32(1) ,107 - 14.
  • 4Irish A. Cantiovaseular disease,fibrinogen and the acute phase response: associations with lipids and blood pressure in patients with chronic renal disease. Atherosclerosis , 1998,137(1), 133 - 9.
  • 5Park CW,Shin YS, Kim CM,et al.Increased C-reactive protein following hemodialysis predicts cardiac hypertrophy in chronic hemodialysis patients. Am J Kidney Dis,2002,40(6), 1230 - 9.
  • 6Torzewski J,Torzewsi M, Bowyer DE, et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioccler Tromb Vasc Biol, 1998,18,1386 - 92.
  • 7Kato A, Odamaki M, Takita T, et al. Association between interleukin-6 and carotid atherosclerosis in hemodialysis patieras. Kidney Int,2002,61(3), 1143 - 52.
  • 8Stenvinkd P, Heimburger O, Jogestrand T. Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: association with Chlamydia pneumoniae seropositivity.Am J Kidney Dis,2002,39(2) ,274 - 82.
  • 9Matsuo K,Ikizler TA, Hoover RL, et al.Tranaforming growth factor-beta is involved in the pathogenesis of dialysis-related amyloidosis. Kidney Int, 2000,57(2) ,697 - 708.
  • 10Mezzano D,Pais EO,Aranda E,et al. Infammation , not hyperhomocysteinemia , is related to oxidative stress and hemoetatic and endothelial dysfunction in uremia. Kidney Int,2001,60(5), 1844 - 50.

共引文献12

同被引文献114

  • 1苏秋菊,荫士安.铁过量对健康的影响[J].国外医学（卫生学分册）,2004,31(6):359-361. 被引量：13
  • 2陈秀益,刘必成,尹莲芳.微炎症反应状态与终末期肾病[J].临床荟萃,2005,20(12):712-715. 被引量：34
  • 3陈香美,孙雪峰,蔡广研.重组人促红细胞生成素在肾性贫血中合理应用的专家共识[J].中国血液净化,2007,6(8):440-443. 被引量：110
  • 4Winkelmayer WC, Kewalramani R, Rutstein M, et al. Phar- macoepidemiology of anemia in kidney transplant recipients [J]. J Am Soc Nephrol, 2010, 15(5): 1347.
  • 5Rigatto C, Parfrey P, Foley, et al. Congestive heart failure in renal transplant recipients: risk factors, outcomes, and rela- tionship with ischemic heart disease[J]. J Am Soc Nephrol, 2009, 13(4): 1084-1090.
  • 6Nangaku M. Hypoxia and tuhulointerstitial injury: a final common pathway to end-stage renal failure[J]. Nephron Exp Nephrol, 2008, 98(1): 8-12.
  • 7Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failureEJ]. J Am Soc Nephrol, 2006, 17(1): 17-25.
  • 8Rossert J, Froissart M. Role of anemia in progression of chro- nic kidney disease[J]. Semin Nephrol, 2006, 26(4) : 283-289.
  • 9Chhabra D, Grafals M, Skaro AI, et al. Impact of anemia af- ter renal transplantation on patient and graft survival and on rate of acute rejection[J]. Clin J Am Soc Nephrol, 2010, 3 (4) : 1168-1174.
  • 10Kawada N, Moriyama T, Ichimaru N, et al. Negative effects of anemia on quality of life and its improvement by complete correction of anemia by administration of recombinant human erythropoietin in posttransplant patients[J]. Clin Exp Neph- rol, 2009, 13(4) : 355-360.

引证文献10

二级引证文献46

中国中西医结合肾病杂志
2012年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部